The SPAC said a virtual meeting of shareholders will be scheduled in early 2021. Nuvation Bio is focused on developing cancer treatments. Read more.
Panacea Files Registration Ahead of Vote on Nuvation Bio Deal
Related Posts
APx Acquisition I Receives Nasdaq Warning for Late Filings
APx in March announced a merger agreement with OmnigenicsAI, a precision medicine company incubated by Bioceres Group, and MultiplAI Health, a UK-based AI-enabled preventive medicine company. If approved, OmnigenicsAI would become a publicly listed company.
Battery Future Acquisition’s NRAs Now Cover 5M+ Shares
Redemptions have removed $68 million from the SPAC's trust.
Greencity Acquisition Files Proxy Seeking 10th Extension
The latest proposal, if approved, would give the SPAC up to six monthly extensions to Oct. 28. In return, the SPAC would deposit 3.3 cents a share into trust for each month.
Edoc Acquisition Signs Share Transfer Agreement with Merger Partner Australian Oilseeds
The transaction had a post-combination valuation of $190 million when announced last December.